Opinion of Advocate General Hogan delivered on 11 September 2019.

Core Citations

WORK EXPRESSION OF in

• Opinion of Advocate General Hogan delivered on 11 September 2019.

This document cites

• Actavis Group PTC EHF and Actavis UK Ltd v Boehringer Ingelheim Pharma GmbH & Co. KG.
• Teva UK Ltd and Others v Gilead Sciences Inc.
• AstraZeneca AB and AstraZeneca plc v European Commission.
• Medeva BV v Comptroller General of Patents, Designs and Trade Marks.
• Merck Sharp & Dohme Corp. v Deutsches Patent- und Markenamt.



See all quotations

• Actavis Group PTC EHF and Actavis UK Ltd v Sanofi.
• Eli Lilly and Company Ltd v Human Genome Sciences Inc.
• Opinion of Advocate General Wathelet delivered on 25 April 2018.
• Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version) (Text with EEA relevance)
• Rules of Procedure of the Court of Justice
• Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (Text with EEA relevance)